The Federal Supply Schedule (FSS) contract awarded to Sterisyn Inc. by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) is for the provision of pharmaceutical and drug products, including gabapentin, TYVASO, and naproxen, to support healthcare programs for veterans nationwide.
The multiple-award IDV contract, valued at up to $50,775,470 through May 2029, allows Sterisyn to deliver pharmaceuticals, drugs, and hematology-related products under pre-negotiated terms and conditions. Recent task orders under this contract include a $13,050 firm fixed price order from the VA VISN 5 network for a TYVASO starter kit to be delivered to a Florida VA facility. As a self-certified small disadvantaged business, Sterisyn may have opportunities for set-aside orders under this contract vehicle to provide affordable, high-quality generic drugs to support VA healthcare programs for veterans.
Generated 2/20/25, 9:03 AM